What do you think of the penalties assessed against drug companies accused of wrongdoing?

Pharmaceutical companies have paid billions of dollars to settle federal allegations of fraud and other wrongdoing in recent years.

In 2009, Eli Lilly and Company agreed to pay a 1.4 billion fine to resolve allegations of off-label promotion of Zyprexa, according to the U.S. Department of Justice (DOJ) website.

In 2012, GlaxoSmithKline agreed to plead guilty and pay a $3 billion fine to resolve fraud allegations and failure to report safety data, the DOJ said.

Recently, a federal jury ordered Takeda Pharmaceutical Co. and Eli Lilly and Company to pay a total of $9 billion in punitive damages after finding that the companies had concealed cancer risks associated with pioglitazone, a diabetes drug.

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters